% | $
Quotes you view appear here for quick access.

Shire plc Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • blackoutbuzz blackoutbuzz Mar 15, 2012 1:46 PM Flag

    SHPGY buys FerroKin Biosciences

    Actually, this is the reason for the drop.

    Shire Plc (SHP) fell in London trading after withdrawing a U.S. application for approval of its Replagal drug for a rare genetic disorder.
    The Food and Drug Administration, which was scheduled to make a decision on the drug in May, will probably now require additional trials of Replagal before approving it as a treatment for Fabry disease, the Dublin-based company said in a statement late yesterday.
    “An approval of Replagal for U.S. patients would only be possible in the distant future,” Shire said in the statement. The decision won’t affect financial forecasts for this year, the company said.